Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life
- 1 September 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 25 (9) , 1011-1019
Abstract
Objective: The menopausal transition is associated with somatic symptoms and increased rates of depression, which can impair quality of life (QOL) and increase cardiovascular disease (CVD) risk. This period is also associated with accelerated vascular aging (arterial stiffening and endothelial dysfunction), an antecedent to CVD. This secondary analysis sought to explore associations between depression, menopausal symptoms and QOL, and vascular aging across menopause stages. Methods: Arterial stiffness (carotid artery compliance), endothelial function (brachial artery flow-mediated dilation [FMD]), menopausal symptoms (Menopausal Symptom List [MSL]), depression (Center for Epidemiologic Studies Depression Scale [CES-D]), and QOL (Utian QOL Scale [UQOL]) were measured in 138 women (19-70 years) classified as premenopausal (n = 41, 34 ± 8 years; mean ± SD), early (n = 25, 49 ± 3 years), or late perimenopausal (n = 26, 50 ± 4 years), or early (n = 22, 55 ± 4 years) or late postmenopausal (n = 24, 61 ± 5 years). Differences across menopause stages were determined using one-way analysis of variance; associations between vascular measures and MSL, CES-D, and UQOL were tested using Pearson's correlation analyses. Results: Menopausal symptoms, depression, and QOL worsened across menopause stages, particularly in late perimenopausal women. Vasosomatic symptom frequency, and general somatic symptom frequency and severity were inversely correlated with carotid artery compliance and FMD (r = −0.27 to −0.18, all P < 0.05). Only correlations with general somatic symptoms were significant after adjusting for multiple comparisons. Total QOL was positively correlated with carotid artery compliance (r = 0.23, P = 0.01). CES-D scores were not correlated with carotid artery compliance or FMD (r = −0.08, −0.03, P = 0.35). Conclusions: Vascular dysfunction across the stages of menopause was associated with greater frequency and severity of menopausal symptoms, and lower QOL, but not depression. Mechanisms underlying these associations (eg, inflammation, oxidative stress) should be explored.Keywords
This publication has 67 references indexed in Scilit:
- Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal womenAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Mood and Menopause: Findings from the Study of Women's Health Across the Nation (SWAN) over 10 YearsObstetrics and Gynecology Clinics of North America, 2011
- Depressive symptoms are related to progression of coronary calcium in midlife women: The Study of Women's Health Across the Nation (SWAN) Heart StudyAmerican Heart Journal, 2011
- Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN)Psychological Medicine, 2011
- Recurrent Major Depression Predicts Progression of Coronary Calcification in Healthy Women: Study of Women's Health Across the NationPsychosomatic Medicine, 2010
- Hopelessness, Depressive Symptoms, and Carotid Atherosclerosis in WomenStroke, 2009
- Hot Flashes and Subclinical Cardiovascular DiseaseCirculation, 2008
- Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN)Journal of Affective Disorders, 2007
- Epidemiology of Major Depressive DisorderArchives of General Psychiatry, 2005
- The CES-D ScaleApplied Psychological Measurement, 1977